ly2922470
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01746017)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Free fatty acid receptor 1AGONIST
FFAR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ly2922470
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01867216 | Phase 1 | Jun 1, 2013 | Eli Lilly |
| NCT01746017 | Phase 1 | Dec 1, 2012 | Eli Lilly |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 2 | 2 | 1 | 2012 |
1 organizations
Page 1 / 1